Figure 3.

Monthly expenditure on anti-rheumatic drugs under the PBS and RPBS, August 2003–July 2005. Note: Expenditure on DMARDs was obtained from the Drug Utilization Sub-Committee database. DMARDs included: methotrexate, azathioprine, cyclophosphamide, cyclosporin, hydroxychloroquine, penicillamine, sulfasalazine, gold preparations (sodium aurothiomalate and auranofin), and leflunomide.